Case Number 6493
Request Date 21/01/2019
Completion Date 31/01/2019

 

Details of the Request

1) The total number of medicines that your trust considered to be facing a shortage throughout:

  • 2016/17
  • 2017/18
  • 2018/19 to date

 

2) A list of the medicines considered to be in short supply for each year:

  • 2016/17
  • 2017/18
  • 2018/19 to date

 

3) The total amount of money your trust spent in response to these medicines shortages – including the cost of finding and procuring alternative medicines – in:

  • 2016/17
  • 2017/18
  • 2018/19 to date

 

4) A breakdown of what this cost includes, if it includes costs other than that of finding and procuring alternative medicines, for each year listed above.

 

Details of the Response

The Trust does not track data in the way you have requested. You have agreed that we respond to the following request:

 

How many order lines were cancelled due to stock not being available/not delivered due to short supply?

We have attached, by month, the number of order lines cancelled due to the desired brand being unavailable, since March 2017. This should not necessarily be interpreted as supplier shortages but as a general measure of the number of interventions made per month due to a medicine not being delivered because it became out of stock with the supplier.

This only represents medicines which were ordered because they were thought to be in stock. It does not represent those medicines which were never ordered because we knew they were out of stock as a result of national or supplier warnings.

The figures in November and December 2018 are lower than previous because we have changed our process, instead of cancelling all to-follows when we substitute them, we now leave a large portion on to-follow so that they can be delivered when they do become ‘in stock’ again. This change in process should not be interpreted as a resolution of the problem of supplier shortages.